Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBodycote Regulatory News (BOY)

Share Price Information for Bodycote (BOY)

Share Price is delayed by 15 minutes
Get Live Data
680.00    -13.00 (-1.88%)
Bid:
679.50
Ask:
681.00
Spread: 1.50 (0.221%)
Market Cap: £1.16b
BOY Live PriceLast checked at - London Stock Exchange

Intraday Bodycote Share Chart

Divisional re-statement for enhanced Optimise programme

18 Nov 2025 07:05

Bodycote Plc - Divisional re-statement for enhanced Optimise programme

Bodycote Plc - Divisional re-statement for enhanced Optimise programme

PR Newswire

LONDON, United Kingdom, November 18

18 November 2025

Bodycote plc

Divisional re-statement for enhanced Optimise programme

 

 

Bodycote, the world's leading provider of specialist thermal processing services, today publishes historical financial information for 2024 and the first half of 2025 reflecting a new divisional reporting structure.

 

At our Half Year results on 30 July 2025 we announced an expansion to the scope of our ongoing Optimise programme. The revised and final programme, which includes 30 plants, will deliver an improved run-rate profit benefit of at least £15m by mid-2027 for a net cash cost of £10-15m. As a result of this expanded scope, the additional plants will now be classified as Non-Core. Our Full Year 2025 results will be presented based on this updated structure.

 

The tables below show our H1 2024, FY 2024 and H1 2025 divisional performance on the new re-classified basis. The historical financial information contained in the following tables is unaudited.

 

 

Half year to 30 June 2025

Specialist Technologies

Precision Heat Treatment

Central costs and eliminations

Total Core

Non-Core

Total Group

£m

£m

£m

£m

£m

£m

Revenue

104.5

232.1

-

336.6

32.4

369.0

Adjusted operating profit/(loss)

27.2

34.9

(8.6)

53.5

1.6

55.1

Return on sales

26.0%

15.0%

 

15.9%

4.9%

14.9%

 

 

 

Half year to 30 June 2024

 

 

Specialist Technologies

Precision Heat Treatment

Central costs and eliminations

Total Core

Non-Core

Total Group

£m

£m

£m

£m

£m

£m

Revenue

115.3

243.0

-

358.3

40.7

399.0

Adjusted operating profit/(loss)

34.4

40.4

(10.2)

64.6

2.2

66.8

Return on sales

29.8%

16.6%

 

18.0%

5.4%

16.7%

 

 

 

2024 FY

 

 

Specialist Technologies

Precision Heat Treatment

Central costs and eliminations

Total Core

Non-Core

Total Group

£m

£m

£m

£m

£m

£m

Revenue

222.3

459.8

-

682.1

75.0

757.1

Adjusted operating profit/(loss)

65.5

80.4

(20.4)

125.5

3.5

129.0

Return on sales

29.5%

17.5%

 

18.4%

4.7%

17.0%

 

 

 

 

 

 

For further information, please contact:

 

Bodycote plc

Jim Fairbairn, Chief Executive Officer

Ben Fidler, Chief Financial Officer

Peter Lapthorn, Investor Relations and FP&A

Tel: +44 1625 505 300

 

Disclosures:

This announcement contains forward-looking statements based on current expectations and assumptions. Various known and unknown risks, uncertainties and other factors may cause actual results to differ from future results or developments expressed or implied from the forward-looking statements. Each forward-looking statement speaks only as of the date of this document. Bodycote plc accepts no obligation to revise or update these forward-looking statements publicly or adjust them to future events or developments, whether as a result of new information, future events or otherwise, except to the extent legally required.

 



Date   Source Headline
15th Jan 20187:00 amRNSUS TAX LEGISLATION AND TRADING UPDATE
20th Dec 20177:00 amRNSOUTSOURCING AGREEMENT WITH DONCASTERS
15th Dec 20177:00 amRNSAppointment of Non-Executive Director
30th Nov 20175:00 pmPRNTotal Voting Rights
8th Nov 20171:10 pmPRNDirector/PDMR Shareholding
3rd Nov 20171:09 pmPRNHolding(s) in Company
1st Nov 201712:18 pmPRNHolding(s) in Company
31st Oct 20175:00 pmPRNTotal Voting Rights
31st Oct 20177:00 amPRNDirectorate Change
26th Oct 20177:00 amRNSTrading Update
16th Oct 20174:34 pmPRNHolding(s) in Company
10th Oct 20172:40 pmPRNHolding(s) in Company
9th Oct 20173:33 pmPRNHolding(s) in Company
6th Oct 20175:16 pmPRNHolding(s) in Company
29th Sep 20174:30 pmPRNTotal Voting Rights
19th Sep 20173:00 pmRNSHolding(s) in Company
18th Sep 20171:42 pmRNSHolding(s) in Company
15th Sep 20171:05 pmRNSHolding(s) in Company
12th Sep 201711:38 amPRNHolding(s) in Company
4th Sep 20172:53 pmPRNHolding(s) in Company
31st Aug 20175:00 pmPRNTotal Voting Rights
21st Aug 201711:24 amRNSHolding(s) in Company
17th Aug 201712:49 pmRNSHolding(s) in Company
31st Jul 20175:00 pmPRNTotal Voting Rights
31st Jul 20174:22 pmPRNDirector/PDMR Shareholding
27th Jul 20177:00 amRNSBodycote plc Half Year results
20th Jul 20177:00 amRNSBodycote Launches Powdermet Technologies
30th Jun 201711:34 amPRNTotal Voting Rights
26th Jun 20172:56 pmPRNHolding(s) in Company
20th Jun 20175:17 pmPRNHolding(s) in Company
20th Jun 20179:36 amPRNHolding(s) in Company
16th Jun 20175:06 pmPRNHolding(s) in Company
12th Jun 20173:54 pmRNSHolding(s) in Company
6th Jun 20179:43 amPRNDirector/PDMR Shareholding
2nd Jun 20175:42 pmPRNHolding(s) in Company
31st May 20175:00 pmPRNTotal Voting Rights
19th May 201712:35 pmPRNHolding(s) in Company
19th May 20178:15 amPRNDirector/PDMR Shareholding
17th May 20177:00 amRNSTrading Update
16th May 201712:51 pmPRNHolding(s) in Company
2nd May 20178:41 amPRNHolding(s) in Company
28th Apr 20175:00 pmPRNTotal Voting Rights
19th Apr 20179:12 amPRNCorrection : Annual Financial Report announcements
13th Apr 20174:32 pmPRNHolding(s) in Company
31st Mar 20174:30 pmPRNTotal Voting Rights
30th Mar 20177:00 amRNSDirectorate Change
21st Mar 20177:00 amPRNAnnual Financial Report announcements
16th Mar 20179:33 amPRNDirector/PDMR Shareholding
10th Mar 20173:08 pmPRNHolding(s) in Company
9th Mar 20174:51 pmPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.